#London #United Kingdom #MRgFUS #Queen Square #FAT1-imaging

A Breakthrough in Essential Tremor Treatment at Queen Square Imaging Centre

In a groundbreaking development for essential tremor patients, a team of renowned neurosurgeons from the Queen Square Imaging Centre in London has introduced a revolutionary imaging technique. This innovation, known as FAT1 imaging, significantly increases the accuracy and effectiveness of a non-invasive treatment called MRI-guided focused ultrasound (MRgFUS). This advancement is crucial, as more than a million individuals in the UK and millions globally are affected by essential tremor, a condition characterized by uncontrollable shaking that severely impacts quality of life.

Traditional Treatment Limitations

Traditionally, medications have been the first line of defense against essential tremor. However, for many patients, these drugs do not provide lasting relief, leading to more invasive interventions. Techniques such as deep brain stimulation (DBS) and radiofrequency ablation (RFA) require surgical procedures and are often accompanied by significant risks and recovery times. Thus, the introduction of MRgFUS, especially with the integration of FAT1 imaging, marks a pivotal shift in the treatment paradigm.

The FAT1 Imaging Technique

FAT1 imaging is a sophisticated MRI method that merges various scanning types, creating a detailed view of the brain structures that surgeons need to target. Specifically, it provides a direct visualization of the ventral intermediate nucleus (Vim), a tiny area in the brain responsible for tremors. Traditional imaging techniques rely on generalized brain maps to estimate this location, which can often lead to inaccuracies during treatment.

Consultant neurosurgeon Harith Akram, who spearheaded this research, stated, "FAT1 imaging is a game-changer. By improving the visibility of brain structures, we can deliver this non-invasive treatment with greater precision, resulting in faster outcomes and fewer side effects. This significantly enhances the lives of our patients."

Study Highlights and Results

In an initial study involving 14 patients treated with FAT1-guided MRgFUS, the results were promising:

• - 60% reduction in tremors observed at 12 months post-procedure.
• - All participants reported an improved quality of life.
• - Side effects were mild and temporary, leading to shorter recovery periods and an overall reduction in energy consumption during procedures.
• - Treatment was executed with precise targeting, enhancing efficacy on the first attempt.

The absence of cuts and implants, as seen in other treatments, indicates that MRgFUS will likely become a preferred option for eligible patients who have not found relief with medications. "This research signifies the future of tremor treatment," Akram remarked, emphasizing the advantages of personalized care through advanced techniques like FAT1 imaging.

Conclusion

FAT1 imaging not only transforms how procedures are conducted but also opens the door for a more customized approach to treatment, ensuring a higher chance for patients to regain their lives free from tremors. While the research is promising, experts advise that patients discuss their conditions with their neurologists or movement disorder specialists before proceeding with any new treatments. The Queen Square Imaging Centre remains at the forefront of neurology, dedicated to advancing treatment through continuous research and innovation. Together with UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, their commitment to patient care and research is unparalleled.

Further Information

This groundbreaking study is published in the BMJ Neurology Open. For additional details, you can access the research article here.